Plasma and urinary oestrogens in breast cancer patients on treatment with 4-hydroxyandrostenedione.
about
Combined treatment with 4-hydroxyandrostenedione and aminoglutethimide: effects on aromatase inhibition and oestrogen suppression.Endocrinological and clinical evaluation of two doses of formestane in advanced breast cancerPhase I trial of the androgen receptor modulator CR1447 in breast cancer.Aromatase inhibitors: from bench to bedside and back.Relations between sex hormones, sex hormone binding globulin, insulin-like growth factor-I and insulin-like growth factor binding protein-1 in post-menopausal breast cancer patients.
P2860
Plasma and urinary oestrogens in breast cancer patients on treatment with 4-hydroxyandrostenedione.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Plasma and urinary oestrogens ...... with 4-hydroxyandrostenedione.
@ast
Plasma and urinary oestrogens ...... with 4-hydroxyandrostenedione.
@en
type
label
Plasma and urinary oestrogens ...... with 4-hydroxyandrostenedione.
@ast
Plasma and urinary oestrogens ...... with 4-hydroxyandrostenedione.
@en
prefLabel
Plasma and urinary oestrogens ...... with 4-hydroxyandrostenedione.
@ast
Plasma and urinary oestrogens ...... with 4-hydroxyandrostenedione.
@en
P2093
P2860
P356
P1476
Plasma and urinary oestrogens ...... with 4-hydroxyandrostenedione.
@en
P2093
Adlercreutz H
Johannessen DC
P2860
P2888
P304
P356
10.1038/BJC.1993.347
P407
P577
1993-08-01T00:00:00Z